Tyndall M - Search Results

1

Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users.

Kerr T, Fairbairn N, Tyndall M, Marsh D, Li K, Montaner J, Wood E. Kerr T, et al. Among authors: tyndall m. Drug Alcohol Depend. 2007 Feb 23;87(1):39-45. doi: 10.1016/j.drugalcdep.2006.07.009. Epub 2006 Sep 7. Drug Alcohol Depend. 2007. PMID: 16959438

2

Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.

Spittal PM, Craib KJ, Wood E, Laliberté N, Li K, Tyndall MW, O'Shaughnessy MV, Schechter MT. Spittal PM, et al. Among authors: tyndall mw. CMAJ. 2002 Apr 2;166(7):894-9. CMAJ. 2002. PMID: 11949985 Free PMC article.

3

The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users.

Wood E, Kerr T, Spittal PM, Li K, Small W, Tyndall MW, Hogg RS, O'Shaughnessy MV, Schechter MT. Wood E, et al. Among authors: tyndall mw. J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):2-8. doi: 10.1097/00126334-200301010-00002. J Acquir Immune Defic Syndr. 2003. PMID: 12514408

4

Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver.

Craib KJ, Spittal PM, Wood E, Laliberte N, Hogg RS, Li K, Heath K, Tyndall MW, O'Shaughnessy MV, Schechter MT. Craib KJ, et al. Among authors: tyndall mw. CMAJ. 2003 Jan 7;168(1):19-24. CMAJ. 2003. PMID: 12515780 Free PMC article.

5

Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside.

Kerr T, Wood E, Small D, Palepu A, Tyndall MW. Kerr T, et al. CMAJ. 2003 Oct 14;169(8):759-63. CMAJ. 2003. PMID: 14557313 Free PMC article.

6

Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users.

Wood E, Montaner JS, Yip B, Tyndall MW, Schechter MT, O'Shaughnessy MV, Hogg RS. Wood E, et al. Antivir Ther. 2004 Apr;9(2):229-35. Antivir Ther. 2004. PMID: 15134185 Clinical Trial.

7

Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users.

Wood E, Kerr T, Small W, Li K, Marsh DC, Montaner JS, Tyndall MW. Wood E, et al. CMAJ. 2004 Sep 28;171(7):731-4. doi: 10.1503/cmaj.1040774. CMAJ. 2004. PMID: 15451834 Free PMC article.

8

Potential uptake and correlates of willingness to use a supervised smoking facility for noninjection illicit drug use.

Collins CL, Kerr T, Kuyper LM, Li K, Tyndall MW, Marsh DC, Montaner JS, Wood E. Collins CL, et al. Among authors: tyndall mw. J Urban Health. 2005 Jun;82(2):276-84. doi: 10.1093/jurban/jti051. Epub 2005 May 4. J Urban Health. 2005. PMID: 15872188 Free PMC article.

9

A description of a peer-run supervised injection site for injection drug users.

Kerr T, Oleson M, Tyndall MW, Montaner J, Wood E. Kerr T, et al. Among authors: tyndall mw. J Urban Health. 2005 Jun;82(2):267-75. doi: 10.1093/jurban/jti050. Epub 2005 May 4. J Urban Health. 2005. PMID: 15872193 Free PMC article.

10

Do supervised injecting facilities attract higher-risk injection drug users?

Wood E, Tyndall MW, Li K, Lloyd-Smith E, Small W, Montaner JS, Kerr T. Wood E, et al. Am J Prev Med. 2005 Aug;29(2):126-30. doi: 10.1016/j.amepre.2005.04.011. Am J Prev Med. 2005. PMID: 16005809

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters